Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can gentle oscillations help premature babies breathe better?

NCT ID NCT01277874

Disease control Sponsor: University of Utah Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This trial tests whether adding gentle oscillations to standard nasal continuous positive airway pressure (NCPAP) improves breathing support for newborns with respiratory distress syndrome. Premature infants who need NCPAP will be randomly assigned to receive either oscillatory NCPAP or standard NCPAP. Researchers will compare how well each method stabilizes breathing, reduces the need for mechanical ventilation, and shortens the time on respiratory support.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Oscillatory nasal continuous airway pressure (Osc-NCPAP), a device that adds oscillations to standard NCPAP delivered via nasal prongs
What this could lead to
If oscillatory NCPAP works better than standard NCPAP, it could reduce the need for mechanical ventilation in premature infants and improve their breathing stability.
What could go wrong
This is an early-stage trial with a small number of participants, so results may not be conclusive. The added oscillations could also cause discomfort or other unforeseen issues in fragile newborns.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Start date

Dec 2014

Expected to finish

Apr 2017

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Up to 28 days

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Newborn (0-28 days of age) admitted to Neonatal Intensive Care Unit (NICU) * Ordered respiratory treatment of NCPAP Exclusion Criteria: * Major congenital defect * Known or suspected chromosomal disorder

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Prematurity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

adult acute respiratory distress syndrome Premature Birth respiratory distress syndrome in premature infants

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Prematurity Respiratory distress syndrome

Contacts and locations

Locations

  • Primary Children's Medical Center

    Salt Lake City, Utah, 84113, United States

  • University of Utah Health Sciences Center

    Salt Lake City, Utah, 84132, United States

  • Valley Children's Healthcare

    Madera, California, 93636, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.